MEDICAL DEVICE USER FEES SOUGHT BY FDA IN FY 1997 BUDGET REQUEST TO WHITE HOUSE; FDA DEPUTY COMMISSIONER SCHULTZ REITERATES FDA SUPPORT FOR ADDITIVE FEES
This article was originally published in The Gray Sheet
FDA is seeking about $23.7 mil. in additive device user fees in the fiscal year 1997 (beginning Oct. 1) budget request pending at the Office of Management and Budget. The level of device user fee funding, which would enable the addition of 109 full-time equivalent staff positions to work on improving device review times, is the same that FDA unsuccessfully proposed in its fiscal 1996 budget request ("The Gray Sheet" Feb. 13, 1995, p. 6).
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.